
The newly created Chair in Thoracic Oncology is in honor of thoracic oncologist Thierry Jahan, M.D.

A benefit for Lung Cancer Research and to celebrate the Addario Lung Cancer Medical Institute.
A gift to the Thoracic Oncology Progam helps us discover new treatments and cures for lung cancer, esophageal cancer and mesothelioma.
As lung cancer kills more women, a call for better
diagnosis, care
San Francisco Chronicle - November 17, 2006
View article
Alicia's Story, Cancer, Despair, Hope
San Francisco Chronicle - June 6, 2006
View
article
New cancer drugs -- off to strong start on long journey
San Francisco Chronicle - June 14, 2004
"When I started out, anybody with advanced lung cancer was given
a pat on the back and a 'good luck,' " said Jahan at UCSF. "We went
from essentially no treatment options to not only realizing
treatments are effective, but we're able to push back the clock for
a lot of people. It's not unusual to see people live, and live
well, for three or five years."
View
article
Thierry Jahan, M.D. is the one of the region's foremost and highly regarded thoracic oncologists. Dr. Jahan has devoted his life to treating patients with lung cancer, mesothelioma and sarcoma. In addition to his keen clinical insight, Dr. Jahan is known by patients, their families and fellow clinicians for his sense of empathy and compassion. His commitment to wiping out lung cancer can be seen in the pins and ribbons that adorn his white coat, a message of hope he carries symbolically to patients as they battle a cruel disease.
Dr. Jahan received his M.D. from George Washington University. He completed his residency and an internal medicine fellowship at Cedars Sinai Medical Center in Los Angeles, followed by a fellowship in hematology and oncology at UCSF. In 1994, Dr. Jahan joined the UCSF faculty and later, with Dr. David M. Jablons, cofounded the Thoracic Oncology Program. Dr. Jahan currently holds the title of Associate Professor of Medicine at the UCSF School of Medicine.
Dr. Jahan has been the recipient of numerous awards including the Medical House Staff Outstanding Teacher Award and Friend of the Palliative Care Service Award. He is also a member of numerous professional organizations, including the American College of Physicians, American Society of Clinical Oncology (ASCO), and International Association for the Study of Lung Cancer (IASLC) and the Association of Northern California Oncologists.
Dr. Jahan has authored or co-authored numerous peer-reviewed articles, book chapters and research abstracts and lectured nationally and internationally on lung cancer and mesothelioma. The San Francisco Chronicle, Time Magazine and KPIX in San Francisco have each sought out his insights and observations on the clinical and human side of battling serious life-threatening cancers.
The Bonnie J. and Anthony Addario Endowed Chair in Thoracic Oncology has been created in the Department of Surgery in honor of Thierry Jahan, M.D., an Associate Professor of Medicine at UCSF, who will occupy the Chair as its first recipient. Dr. Jahan is the one of the region's most highly regarded thoracic oncologists and sarcoma specialists, known among patients, their families, and colleagues for his deep sense of empathy and compassion. Dr. Jahan co-founded the multidisciplinary Thoracic Oncology Program with David Jablons, Chief of the Section of General Thoracic Surgery. On July 9, 2009, there was a celebration held at the Kalmonovitz Library at UCSF to honor Dr. Jahan and his appointment to the newly created Chair.
"Soft tissue sarcomas are extraordinarily heterogeneous, so experience is particularly important when deciding among treatment options," says medical oncologist Thierry M. Jahan, M.D. (pictured right). At UCSF, referring physicians typically send patients with painful, growing soft tissue masses to orthopaedic surgeon Richard J. O'Donnell, M.D., and general surgeon Eric K. Nakakura, M.D., Ph.D, (pictured left). If their initial examination convinces them that there is a sarcoma concern, they move on to a staging workup that includes various imaging modalities and, eventually, either a needle or incisional biopsy...."
"The San Francisco man has survived a rare form of
thoracic cancer called thymoma that had him in a coma for seven
weeks, required months of rehabilitation and left him with one
lung. Today, he's back at work directing the choir of 30 boys and
12 men at the Episcopalian cathedral, where music is a medium for
his continued healing.
Putnam, 34, is alive today thanks to the efforts of a UCSF Medical
Center team that included thoracic surgeon David Jablons, MD, who
removed the tumor and infected right lung last march, and
oncologist Thierry Jahan, MD, who directed his chemotherapy before
the surgery ........